Patents by Inventor Seung Je MIN

Seung Je MIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12037338
    Abstract: The present disclosure provides a compound of Chemical Formula (1) or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the same: wherein X, Z, R1 and R2 are as defined in the specification. The compound of Chemical Formula (1) or pharmaceutically acceptable salt thereof acts as a positive allosteric modulator of metabotropic glutamate receptor subtype 5 (mGluR5), thereby being useful in the prevention or treatment of disorder mediated by glutamate dysfunction and mGluR5.
    Type: Grant
    Filed: June 1, 2021
    Date of Patent: July 16, 2024
    Assignee: SK BIOPHARMACEUTICALS CO., LTD.
    Inventors: Chun Eung Park, Young Koo Jang, Yong Je Shin, Ji Yeon Kim, Seung Mo Ham, Yong Gil Kim, Hye Kyung Min, Soo Bong Cha, Hyo Jun Jung, Ju Young Lee, Seung Nam Han, Jin Yong Chung, Eun Ju Choi, Chan Mi Joung, Jong Sil Park, Ji Won Lee, Nahm Ryune Cho, Eun Ju Ryu, Cheol Young Maeng
  • Patent number: 11958897
    Abstract: The present invention relates to an anti-VAMP2 antibody that inhibits SNARE complex and uses thereof, and more specifically, the present invention relates to an anti-VAMP2 antibody or antigen-binding fragments thereof comprising heavy and light chain CDRs of a specific sequence. The anti-VAMP2 antibody is expected to be useful for improving or treating skin wrinkles by inhibiting SNARE complex formation.
    Type: Grant
    Filed: August 14, 2019
    Date of Patent: April 16, 2024
    Assignee: HAUUL BIO
    Inventors: Hee-Jun Na, Yun-Suk Lee, Je-Ok Yoo, Kwang-Soon Lee, Kang Seung Lee, Seung Je Min
  • Publication number: 20230242637
    Abstract: The present disclosure relates to an anti-SNAP 25 antibody for inhibiting a SNARE complex, and a use thereof and, more specifically, to an anti-SNAP 25 antibody comprising heavy chain CDRs and light chain CDRs of specific sequences, or an antigen-binding fragment thereof. The anti-snap 25 antibody inhibits the formation of a SNARE complex, and thus is expected to be advantageously used for reducing or treating skin wrinkles.
    Type: Application
    Filed: October 14, 2020
    Publication date: August 3, 2023
    Applicant: HAUUL BIO
    Inventors: Hee-Jun NA, Yun-Suk LEE, Je-Ok YOO, Kwang-Soon LEE, Kangseung LEE, Seung Je MIN, Ji Won KANG
  • Publication number: 20220213220
    Abstract: The present invention relates to an anti-tyrosinase antibody for inhibiting tyrosinase and use thereof, and more particularly, to an anti-tyrosinase antibody including a heavy chain CDR and a light chain CDR of specific sequences, or an antigen-binding fragment thereof. The anti-tyrosinase antibody is expected to be effectively utilized for improving skin whitening or treating skin pigmentation disorders by inhibiting tyrosinase activity.
    Type: Application
    Filed: December 13, 2019
    Publication date: July 7, 2022
    Applicant: HAUUL BIO
    Inventors: Hee-Jun NA, Yun-Suk LEE, Je-Ok YOO, Kwang-Soon LEE, Kang Seung LEE, Seung Je MIN
  • Publication number: 20210198348
    Abstract: The present invention relates to an anti-VAMP2 antibody that inhibits SNARE complex and uses thereof, and more specifically, the present invention relates to an anti-VAMP2 antibody or antigen-binding fragments thereof comprising heavy and light chain CDRs of a specific sequence. The anti-VAMP2 antibody is expected to be useful for improving or treating skin wrinkles by inhibiting SNARE complex formation.
    Type: Application
    Filed: August 14, 2019
    Publication date: July 1, 2021
    Applicant: HAUUL BIO
    Inventors: Hee-Jun NA, Yun-Suk LEE, Je-Ok YOO, Kwang-Soon LEE, Kang Seung LEE, Seung Je MIN